Bausch Health, Walgreens program supports lower pricing on many dermatology products

Bausch Health announced the expansion of its dermatology prescription program with Walgreens stores in the U.S.

“Under the expanded agreement, Walgreens patients will have access to certain dermatology products from Bausch Health’s first-of-its-kind cash-pay prescription program, Dermatology.com, at lower flat cash rates ranging from $50 to $115,” according to a press release from the companies.

The program was launched under Ortho Dermatologics in March, and by the end of August will be available at more than 9,500 Walgreens U.S. retail pharmacy locations.

The suite of products in the program treats a range of dermatological conditions such as actinic keratosis, acne, barrier repair and corticosteroid-responsive diseases, according to the release.

“Through our collaboration with Bausch Health, we are able to offer a set pricing model that provides patients the security of knowing the cost of their dermatology prescriptions each time they refill them at Walgreens while decreasing complexities and processes to allow our pharmacists to focus on providing advice and support to patients,” Alex Gourlay, co-chief operating officer for Walgreens Boots Alliance Inc., said in the release.

 

Bausch Health announced the expansion of its dermatology prescription program with Walgreens stores in the U.S.

“Under the expanded agreement, Walgreens patients will have access to certain dermatology products from Bausch Health’s first-of-its-kind cash-pay prescription program, Dermatology.com, at lower flat cash rates ranging from $50 to $115,” according to a press release from the companies.

The program was launched under Ortho Dermatologics in March, and by the end of August will be available at more than 9,500 Walgreens U.S. retail pharmacy locations.

The suite of products in the program treats a range of dermatological conditions such as actinic keratosis, acne, barrier repair and corticosteroid-responsive diseases, according to the release.

“Through our collaboration with Bausch Health, we are able to offer a set pricing model that provides patients the security of knowing the cost of their dermatology prescriptions each time they refill them at Walgreens while decreasing complexities and processes to allow our pharmacists to focus on providing advice and support to patients,” Alex Gourlay, co-chief operating officer for Walgreens Boots Alliance Inc., said in the release.